Susceptibility-Guided Therapy for Helicobacter Pylori Infection Treatment
Status:
Not yet recruiting
Trial end date:
2023-03-01
Target enrollment:
Participant gender:
Summary
This multicenter randomized controlled clinical trial was conducted to compare the
eradication efficacy and health economic benefits of individualized regimens based on HP drug
resistance mutation gene detection (multiple PCR method), individualized regimens based on HP
traditional drug sensitivity testing (E-test method) and empirical regimens in the
Helicobacter pylori treatment.